Format

Send to

Choose Destination
Am J Infect Control. 2004 Oct;32(6):342-4.

Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital.

Author information

1
Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, USA. wilson@iupui.edu

Abstract

We conducted a case-control study to determine the attributable direct costs of multidrug-resistant Acinetobacter baumannii (MDRAB) in the burn unit of a public teaching hospital. The mean total hospital cost of patients who acquired MDRAB was 98,575 dollars higher than that of control patients who had identical burn severity of illness indices ( P <.01). These data should help infection control practitioners and others determine the cost-effectiveness of specific interventions designed to control this emerging nosocomial pathogen.

PMID:
15454892
DOI:
10.1016/j.ajic.2004.02.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center